EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Bio-pharmaceutics II Pharmacokinetics Exponential drug disappearance biological half life factors influencing blood concentrations use of tissue concentration data in design of dosage forms and dosage regimens evaluation of drugs and drug products



Bio-pharmaceutics II Pharmacokinetics Exponential drug disappearance biological half life factors influencing blood concentrations use of tissue concentration data in design of dosage forms and dosage regimens evaluation of drugs and drug products



Amer J Pharm: 175-193




(PDF emailed within 1 workday: $29.90)

Accession: 024236098

Download citation: RISBibTeXText



Related references

Bio pharmaceutics part 8 relationship between dosage forms dosage regimens and pharmaco kinetics. Drug Intelligence 3(1): 21-27, 1969

Using pharmacokinetics in drug therapy. V: Contributions to developing dosage regimens for antihypertensive drugs. American Journal of Hospital Pharmacy 36(9): 1222-1226, 1979

Clinical pharmacokinetics of antiepileptic drugs. Quantitative variables of drug clearance used for the individual assessment of dosage regimens. Acta Pharmaceutica Suecica 11(6): 663-665, 1975

Using pharmacokinetics in drug therapy. VIII: Pharmacokinetic evaluation of antibiotic dosage regimens. American Journal of Hospital Pharmacy 37(10): 1356-1366, 1980

Factors influencing liberation of drug from semisolid dosage forms. Acta Pharmaceutica Hungarica 70(2): 29-34, 2001

Plasmodium berghei: diet and drug dosage regimens influencing selection of drug-resistant parasites in mice. Experimental Parasitology 55(3): 372-376, 1983

Using pharmacokinetics in drug therapy III: Estimating dosage regimens and blood levels using the fraction-lost method. American Journal of Hospital Pharmacy 35(8): 955-958, 1978

Improving drug dosing in hospitalized patients: automated modeling of pharmacokinetics for individualization of drug dosage regimens. Computer Methods and Programs in Biomedicine 30(2-3): 169-176, 1989

Using pharmacokinetics in drug therapy II: Rapid estimates of dosage regimens and blood levels without knowledge of pharmacokinetic variables. American Journal of Hospital Pharmacy 35(4): 454-459, 1978

Pharmacokinetic estimation for therapeutic dosage regimens (PETDR)--a software program designed to determine intravenous drug dosage regimens for veterinary applications. Journal of Veterinary Pharmacology and Therapeutics 11(4): 390-396, 1988

Materials for pharmaceutical dosage forms: molecular pharmaceutics and controlled release drug delivery aspects. International Journal of Molecular Sciences 11(9): 3298-3322, 2010

The operational multiple dosing half-life: a key to defining drug accumulation in patients and to designing extended release dosage forms. Pharmaceutical Research 25(12): 2869-2877, 2008

A practical framework for implementing Quality by design to the development of topical drug products: Nanosystem-based dosage forms. International Journal of Pharmaceutics, 2018

Practical pharmacokinetic techniques for drug consultation and evaluation. 3. Psychotherapeutic drugs as prototypes for illustrating some considerations in pharmacist-generated dosage regimens. American Journal of Hospital Pharmacy 31(1): 59-66, 1974

Polymer-drug interacted systems in the physicochemical design of pharmaceutical dosage forms. I. Drug salts with PVM-MA and with a PVM-MA hemi-ester. Journal of Pharmaceutical Sciences 57(9): 1598-1603, 1968